Video
Francesco Asnicar, CIBIO - University of Trento (Italy), discusses new large-scale research on the human microbiome, based on the analysis of more than 35,000 individuals from the UK and the…
Industry
Sponsored by
Carlo Sala and Chiara Sironi explain how Sacco System is driving innovation in the probiotic market through research, strain development, and tailored formulations.
Amine Zorgani explains how SwipeBiome moves beyond traditional stool testing toward real-time microbiome prediction based on patient metadata.
Liam O’Mahony explores how diet influences the immune system through the metabolic activity of the gut microbiota.
Giulia Collattuzzo, University of Bologna, presents study findings showing an independent protective association between dietary fiber and gastric cancer risk, with consistent effects across sex, tumor location, and histological subtype.
The fifth edition of IBS Days, a congress entirely dedicated to Irritable Bowel Syndrome, will take place in Bologna, Italy, from June 15 to 17, 2026.
Giuseppe Penna, from Humanitas University (Italy), presents the development of a novel postbiotic obtained from a single bacterial strain through an innovative fermentation process.
Giovanni Marasco, University of Bologna, discusses the growing evidence that links gut microbiota dysbiosis to the pathophysiology, clinical prognosis, disease progression, and treatment response of patients with IBD.
Ivana Gandolfi, International Diary Federation, describes the emerging concept of the food matrix.
Francesco Asnicar, University of Trento (Italy), explores the role of the human gut microbiome in cardiometabolic health and diet, focusing on microbial species linked to metabolic and dietary markers.
